Mountain Valley to proceed with pre-clinical cancer trials, files related cancer patent
Mountain Valley to proceed with pre-clinical cancer trials, files related cancer patent
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Mydecine Innovations, Aion Therapeutic, EVmo, Alpine 4, Arizona Silver UPDATE...
Proactive Investors
Mydecine Innovations Group Inc (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) announced that it ended the first quarter of 2021 with cash..
-
NA Proactive news snapshot: Mydecine Innovations, Aion Therapeutic, EVmo, Alpine 4, Dalrada UPDATE...
Proactive Investors
-
NA Proactive news snapshot: Ayurcann Holdings, HempFusion Wellness, Fireweed Zinc, Fury Gold Mines, Ridgeline Minerals, AIM ImmunoTech UPDATE...
Proactive Investors
-
NA Proactive news snapshot: Tartisan Nickel, Metalla Royalty & Streaming, Dalrada Corporation, Numinus Wellness UPDATE. …
Proactive Investors
-
NA Proactive news snapshot: Dalrada Corporation, Numinus Wellness, Predictiv AI, Kodiak Copper UPDATE. …
Proactive Investors
Advertisement
More coverage
Mountain Valley MD Holdings updates on "encouraging" progress in its pre-clinical trial portfolio
Proactive Investors
Mountain Valley MD Holdings Inc (CSE:MVMD) (OTCQB:MVMDF) has provided new insight into its progress on a selection of ongoing..
-
Mountain Valley MD CEO thinks investors should be excited about the company’s ability to bring technology into commercialization this year
Proactive Investors
-
NA Proactive news snapshot: Mountain Valley MD, Zynerba Pharmaceuticals, TRACON Pharmaceuticals, Kainantu Resources, Ready Set Gold UPDATE …
Proactive Investors
-
Dow climbs to a fresh record high, tech weakness sinks Nasdaq
Proactive Investors
-
Mountain Valley MD says it has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials
Proactive Investors